Discounting health and cost-effectiveness analysis: a response to Nord.
نویسنده
چکیده
Nord (2011) criticizes standard arguments which assert that consistency requires that future health benefits must be discounted at the same rate as future costs in cost-effectiveness analysis (CEA). He suggests these arguments are misguided because they require transitivity of preferences across decision contexts and that it can be appropriate to discount health at different rates depending on the programs to be compared. I claim that rejecting transitivity is unwarranted and would sharply diminish the utility of CEA. Factors that tempt Nord to reject consistency can be accommodated by recognizing that CEA does not perfectly mimic normative social preferences because it omits factors (like distribution of health in a population) that can be normatively significant. A better approach is to maintain consistency in application of CEA but authorize decision makers to depart from rankings implied by CEA when justified and to explain which specific factors justify the decision. Finally, the assertion that health must be discounted at the same rate as costs requires the additional assumption that the dollar value of health does not change over time, a point that is not always recognized in standard arguments.
منابع مشابه
Including Both Costs and Effects – The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries
متن کامل
A new study of an EOQ model for deteriorating items with shortages under inflation and time discounting
We discuss the effects of inflation and time discounting on an EOQ model for deteriorating items under stock-dependent demand and time-dependent partial backlogging. The inventory model is studied under the replenishment policy starting with no shortages. We then use MATLAB to find the optimal replenishment policies. The objective of this model is to maximize the total profit (TP) which inclu...
متن کاملEconomic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis
The aim of this study is to assess cost-effectiveness of infliximab, compared with conventional treatments in patients with moderate to severe Ulcerative Colitis (UC) in Iran. We developed an analytical decision model with a 5-year-time horizon to follow up 1000 hypothetical patients, in order to estimate treatment costs and outcomes. Hypothetical patients, were individuals with moderate to sev...
متن کاملDiscounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review.
Discounting future costs and health benefits usually has a large effect on results of cost-effectiveness evaluations of vaccination because of delays between the initial expenditure in the programme and the health benefits from averting disease. Most guidelines currently recommend discounting both costs and health effects at a positive, constant, common rate back to a common point in time. A re...
متن کاملThe Effectiveness of Delayed Discounting Model of Mindfulness-Based Cognitive Therapy on Delayed Reward Discounting, Impulsivity and Sensation Seeking in Individuals with Substance Use Disorders
Objective: The aim of this study was to investigate the effectiveness of delayed discounting model of mindfulness-based cognitive therapy on delayed reward discounting, impulsivity, and sensation seeking in individuals with substance use disorders. Method: This study was a semi-experimental research conducted in the form of pretest-posttest and follow-up stage with control group. The statistica...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Health economics
دوره 21 7 شماره
صفحات -
تاریخ انتشار 2012